Psychedelics Today

← Psychedelics Today7 Oct · 1 h 16 min

PT 661 - Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health

PT 661 - Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health7 Oct1 h 16 min

Kenneth Tupper has spent decades working at the intersection of drug policy, public health, harm reduction, education, and psychedelics.

In this episode, Joe Moore talks with Tupper about his early work with DanceSafe and drug checking, British Columbia's overdose crisis and experiment with decriminalization, and what the psychedelic field can learn from decades of harm reduction work and research.

They also dig into Tupper's academic work on psychedelics and education, the idea of entheogens as "plant teachers," ayahuasca policy in Canada, problems with conventional drug education, and the limits of treating psychedelics exclusively as medicines.

The conversation eventually widens into a bigger question: What does it actually mean to educate people well about drugs, altered states, and consciousness?

Enjoy the show.

Disclaimer: Intro and promotional audio in this episode were generated using synthetic voice technology. The interview itself is unaltered.

Show Notes (Machine Generated)

Kenneth Tupper's career has followed two parallel tracks: psychedelic scholarship and public health. Long before the current psychedelic resurgence, he was studying the idea of entheogens as tools for learning and examining how Indigenous traditions understand plants such as ayahuasca, peyote, and psilocybin as teachers. At the same time, work with DanceSafe and early pill testing drew him into harm reduction and eventually into more than two decades of public-health and drug-policy work in British Columbia.

Tupper and Joe revisit the early history of drug checking and the logic behind harm reduction: if people are going to use drugs, providing accurate information and reducing preventable risks can save lives. That discussion leads into supervised consumption sites, pharmaceutical alternatives to illicit opioids, fentanyl, the toxic drug supply, naloxone, and the difficult reality of people surviving overdoses while sustaining hypoxic or anoxic brain injuries.

They also examine British Columbia's experiment with drug decriminalization. Tupper describes the limits of decriminalizing possession without simultaneously addressing housing, healthcare, treatment options, the illicit supply, and other social conditions. The conversation contrasts British Columbia with Portugal and explores why drug policy interventions cannot easily be transplanted from one social and historical context into another.

From there, the discussion turns directly toward ps